Figure 2.
Relationship between change in A1C from baseline to end point and baseline A1C by treatment group of at-goal (12 or 24 weeks) patients (who provided a baseline A1C): subgroup with fasting insulin > 11.4 μIU/ml and age ≤ 56 years.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.